Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Syndecan binding protein pseudogene 1 (SDCBPP1) is a pseudogene in the human genome with sequence similarity to the syndecan binding protein gene (SDCBP), which encodes the adapter protein syntenin-1. As a pseudogene, SDCBPP1 does not produce a functional protein product and does not participate in cellular or molecular processes. It is not considered a drug target, biomarker, or receptor, and has no established biological or therapeutic roles. For therapeutic or biological relevance, the focus should be on the functional SDCBP gene and the encoded syntenin-1 protein[1][3][5]. In summary: SDCBPP1 is not a true therapeutic target and lacks biological function, so structured data for a therapeutic target should instead reference the active gene or protein—syndecan binding protein (syntenin-1), SDCBP[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Syndecan binding protein pseudogene 1 (SDCBPP1).